Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TFF3 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
mRNA | JAK2 | FIMM | pan-cancer | AAC | 0.47 | 0.008 |
mRNA | C18orf54 | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
mRNA | RASD1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
mRNA | DCANP1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | FGFR1 | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
mRNA | NTMT1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
mRNA | TAF12 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
mRNA | RAB2B | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
mRNA | PICK1 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |